A new AI tool can assess the impact of lifestyle factors such as drinking, smoking, poor diet, and lack of exercise on premature heart aging, with the aim of finding ways to reverse the process and reduce the risks of age-related conditions like stroke and heart disease.
Beijing is taking steps to limit the use of artificial intelligence in online healthcare services, including medical diagnosis, as the technology continues to disrupt traditional occupations and industries in China.
Healthcare providers are beginning to experiment with AI for decision-making and revenue growth, utilizing predictive tools integrated with EMRs and ERPs, automation solutions to streamline workflows, and personalized care and messaging to improve patient retention.
Lotte Healthcare and iMediSync are collaborating to develop AI-driven healthcare services, with a focus on wellness, senior care, and mental health.
Microsoft and Epic are expanding their strategic collaboration to bring generative AI technologies to the healthcare industry, aiming to address urgent needs such as workforce burnout and staffing shortages and enhance patient care and operational efficiency within the Epic electronic health record ecosystem.
Northwell Health, New York's largest health system, is partnering with Aegis Ventures to develop generative AI products that aim to reduce the burden of paperwork and administrative tasks for healthcare providers.
Artificial intelligence technology, such as ChatGPT, has been found to be as accurate as a developing practitioner in clinical decision-making and diagnosis, according to a study by Massachusetts researchers. The technology was 72% accurate in overall decision-making and 77% accurate in making final diagnoses, with no gender or severity bias observed. While it was less successful in differential diagnosis, the researchers believe AI could be valuable in relieving the burden on emergency departments and assisting with triage.
Healthcare technology company Innovaccer has unveiled an AI assistant called "Sara for Healthcare" that aims to automate workflows and offer insights to healthcare leaders, clinicians, care coordinators, and contact center representatives. The suite of AI models has been trained specifically for the healthcare context, with a focus on accuracy and addressing privacy and regulatory requirements. The AI assistant works in conjunction with Innovaccer's platform, which integrates healthcare data from various sources. The suite includes features such as instant answers to questions, help with care management, assistance with EHR administrative tasks, and streamlining contact center workflows.
The use of AI in healthcare has the potential to improve efficiency and reduce costs, but it may also lead to a lack of human compassion and communication with patients, which is crucial in delivering sensitive news and fostering doctor-patient relationships.
The use of AI algorithms by insurance companies to assess claims is raising concerns about potential bias and lack of human oversight, leading Pennsylvania legislators to propose legislation that would regulate the use of AI in claims processing.
Generative AI has the potential to revolutionize healthcare by automating administrative tasks, improving doctor-patient relationships, and enhancing clinical decision-making, but building trust and transparency are essential for its successful integration.
NextGen Healthcare and Luma Health have formed an alliance to provide artificial intelligence-enhanced solutions for patient communications, including appointment reminders, surveys, and self-scheduling. The alliance aims to reduce staff burdens and improve the patient experience.
The MIT Abdul Latif Jameel Clinic for Machine Learning in Health organized a summer program to educate high school students on the use of artificial intelligence (AI) in healthcare, aiming to expose them to the intersection of computer science and medicine and provide new opportunities for underrepresented students.
Artificial intelligence (AI) has the potential to revolutionize healthcare by improving disease detection and diagnosis, enhancing healthcare systems, and benefiting health care providers, but it also presents challenges that must be addressed, such as developing robust and reliable AI models and ensuring ethical and responsible use.
Artificial intelligence (AI) has the potential to support improvements in the clinical validation process, addressing challenges in determining whether conditions can be reported based on clinical information and enhancing efficiency and accuracy in coding and validation.
New research finds that AI chatbots may not always provide accurate information about cancer care, with some recommendations being incorrect or too complex for patients. Despite this, AI is seen as a valuable tool that can improve over time and provide accessible medical information and care.
Scientists have developed an AI model that accurately identifies cardiac functions and valvular heart diseases using chest radiographs, which could improve diagnostic efficiency and be useful in settings lacking specialized technicians.
AI has the potential to revolutionize healthcare by shifting the focus from treating sickness to preventing it, leading to longer and healthier lives, lower healthcare costs, and improved outcomes.
Artificial intelligence (AI) has the potential to greatly improve health care globally by expanding access to health services, according to Google's chief health officer, Karen DeSalvo. Through initiatives such as using AI to monitor search queries for potential self-harm, as well as developing low-cost ultrasound devices and automated screening for tuberculosis, AI can address health-care access gaps and improve patient outcomes.
Artificial intelligence (AI) tools can put human rights at risk, as highlighted by researchers from Amnesty International on the Me, Myself, and AI podcast, who discuss scenarios in which AI is used to track activists and make automated decisions that can lead to discrimination and inequality, emphasizing the need for human intervention and changes in public policy to address these issues.
Artificial intelligence (AI) is being explored as a potential solution to end the opioid epidemic, with innovations ranging from identifying at-risk individuals to detecting drug contamination and reducing overdoses, but concerns about discrimination and misinformation must be addressed.
New AI tools are being developed to help employees take control of their mental health in the workplace, offering real-time insights and recommendations for support, and studies show that a majority of employees are willing to consent to AI-powered mental health tracking.
Artificial Intelligence (AI) has the potential to enrich human lives by offering advantages such as enhanced customer experience, data analysis and insight, automation of repetitive tasks, optimized supply chain, improved healthcare, and empowerment of individuals through personalized learning, assistive technologies, smart home automation, and language translation. It is crucial to stay informed, unite with AI, continuously learn, experiment with AI tools, and consider ethical implications to confidently embrace AI and create a more intelligent and prosperous future.
UF Health in Jacksonville is using artificial intelligence to help doctors diagnose prostate cancer, allowing them to evaluate cases more quickly and accurately. The AI technology, provided by Paige Prostate, assists in distinguishing between benign and malignant tissue, enhancing doctors' abilities without replacing them.
Generative AI models like ChatGPT can produce personalized medical advice, but they often generate inaccurate information, raising concerns about their reliability and potential harm. However, as AI technology advances, it has the potential to complement doctor consultations and improve healthcare outcomes by providing thorough explanations and synthesizing multiple data sources. To ensure responsible progress, patient data security measures, regulatory frameworks, and extensive training for healthcare professionals are necessary.
An AI-generated COVID drug enters clinical trials, GM and Google strengthen their AI partnership, and Israel unveils an advanced AI-powered surveillance plane, among other AI technology advancements.
GE HealthCare and Mass General Brigham have co-developed an artificial intelligence algorithm that predicts missed care opportunities and late arrivals, aiming to increase operational effectiveness and streamline administrative operations in healthcare.
AI-led automation is being used by healthcare institutions and insurance companies to speed up administrative tasks, such as retrieving insurance information and determining coverage for procedures, reducing the time spent on these processes and improving customer service.
Microsoft is partnering with digital pathology provider Paige to develop the world's largest image-based AI model for identifying cancer, which can identify both common and rare cancers and aims to assist doctors in dealing with staffing shortages and growing caseloads. Paige has received FDA approval for its AI viewing tool FullFocus, and with Microsoft's help, it has built an advanced AI model that is training on 4 million slides, making it the largest computer vision model publicly announced. The model aims to improve accuracy and efficiency in pathology and democratize access to healthcare.
Artificial intelligence (AI) is changing the field of cardiology, but it is not replacing cardiologists; instead, it is seen as a tool that can enhance efficiency and improve patient care, although it requires medical supervision and has limitations.
The lack of regulation surrounding artificial intelligence in healthcare is a significant threat, according to the World Health Organization's European regional director, who highlights the need for positive regulation to prevent harm while harnessing AI's potential.
The accuracy of AI chatbots in diagnosing medical conditions may be an improvement over searching symptoms on the internet, but questions remain about how to integrate this technology into healthcare systems with appropriate safeguards and regulation.
AI is being used to transform the healthcare industry in New York while robots have the potential to revolutionize the beauty and cosmetics industry in California, as explained on "Eye on America" with host Michelle Miller.
Artificial intelligence (AI) in healthcare must adopt a more holistic approach that includes small data, such as lived experiences and social determinants of health, in order to address health disparities and biases in treatment plans.
Healthcare revenue cycle management provider Aspirion has acquired Artificial Intelligence (AI) and machine learning firm Infinia ML to enhance operational effectiveness, recovery yield, and collections for its healthcare clients. Infinia ML will operate as Aspirion's research and development engine, focusing on AI capabilities to drive financial performance improvements for healthcare providers.
Researchers at OSF HealthCare in Illinois have developed an artificial intelligence (AI) model that predicts a patient's risk of death within five to 90 days after admission to the hospital, with the aim of facilitating important end-of-life discussions between clinicians and patients. The AI model, tested on a dataset of over 75,000 patients, showed that those identified as more likely to die during their hospital stay had a mortality rate three times higher than the average. The model provides clinicians with a probability and an explanation of the patient's increased risk of death, prompting crucial conversations about end-of-life care.
Scientists at The Feinstein Institutes for Medical Research have been awarded $3.1 million to develop artificial intelligence and machine learning tools to monitor hospitalized patients and predict deterioration, aiming to improve patient outcomes.
Google and the U.S. Department of Defense have developed an Augmented Reality Microscope (ARM) powered by artificial intelligence, which can assist pathologists in diagnosing conditions like cancer by quickly identifying the location and severity of tumors, potentially providing a useful tool for pathologists without easy access to a second opinion.
BioticsAI has developed an AI-based platform that integrates with ultrasound machines to improve the accuracy and efficiency of fetal malformation screenings, providing automated reports and time savings for doctors.
Google Health's chief clinical officer, Michael Howell, discusses the advances in artificial intelligence (AI) that are transforming the field of medicine, emphasizing that AI should be seen as an assistive tool for healthcare professionals rather than a replacement for doctors. He highlights the significant improvements in AI models' ability to answer medical questions and provide patient care suggestions, but also acknowledges the challenges of avoiding AI gaslighting and hallucinations and protecting patient privacy and safety.
Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.
